Director of Shandong Cancer Hospital and Institute
Latest Information Update: 18 Jul 2024
At a glance
- Drugs Adebrelimab (Primary) ; Carboplatin (Primary) ; Cisplatin (Primary) ; Etoposide (Primary)
- Indications Small cell lung cancer
- Focus Therapeutic Use
- 03 Jul 2024 Planned End Date changed from 1 Dec 2023 to 1 Oct 2024.
- 03 Jul 2024 Planned primary completion date changed from 1 Sep 2023 to 1 Oct 2024.
- 03 Jul 2024 Status changed from recruiting to active, no longer recruiting.